Literature DB >> 12242670

The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.

André T Hoogeveen1, Stefano Rossetti, Violeta Stoyanova, Joris Schonkeren, Angelia Fenaroli, Luisa Schiaffonati, Leontine van Unen, Nicoletta Sacchi.   

Abstract

The MTG (Myeloid Translocation Gene) proteins are a family of novel transcriptional corepressors. We report that MTG16a, a protein isoform encoded by the MTG16 gene deranged by the t (16; 21) in myeloid malignancies, is targeted to the nucleolus. The amino acid sequence necessary for nucleolar localization was mapped to the MTG16a N-terminal region. MTG16a, like MTG8, the nuclear corepressor deranged by the t (8; 21), is capable to interact with specific histone deacetylases (HDACs) suggesting that the protein may mediate silencing of nucleolar gene transcription. In addition, MTG16a is capable to form oligomers with other MTG proteins. As a consequence of the t (16; 21) the AML1 DNA-binding domain replaces the MTG16a N-terminal region. The AML1-MTG16 fusion protein is targeted to the nucleoplasm where it is capable to oligomerize with MTG16a and interact with HDAC1 and HDAC3. The deficiency of HDAC-containing complexes at nucleolar sites and the accumulation of HDAC-containing complexes at AML1-sites may be critical in the pathogenesis of t (16; 21) myeloid malignancies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242670     DOI: 10.1038/sj.onc.1205882

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Authors:  Matteo Brioschi; John Fischer; Roberto Cairoli; Stefano Rossetti; Laura Pezzetti; Michele Nichelatti; Mauro Turrini; Francesca Corlazzoli; Barbara Scarpati; Enrica Morra; Nicoletta Sacchi; Alessandro Beghini
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  E proteins orchestrate dynamic transcriptional cascades implicated in the suppression of the differentiation of group 2 innate lymphoid cells.

Authors:  Vincent Peng; Constantin Georgescu; Anna Bakowska; Aneta Pankow; Liangyue Qian; Jonathan D Wren; Xiao-Hong Sun
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

Review 3.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 4.  Bioinformatic analysis of the nucleolus.

Authors:  Anthony K L Leung; Jens S Andersen; Matthias Mann; Angus I Lamond
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

5.  Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.

Authors:  Ying Cai; Zhixiong Xu; Jingping Xie; Amy-Joan L Ham; Mark J Koury; Scott W Hiebert; Stephen J Brandt
Journal:  Biochem Biophys Res Commun       Date:  2009-09-30       Impact factor: 3.575

6.  A distinct epigenetic signature at targets of a leukemia protein.

Authors:  Stefano Rossetti; André T Hoogeveen; Ping Liang; Cornel Stanciu; Peter van der Spek; Nicoletta Sacchi
Journal:  BMC Genomics       Date:  2007-02-01       Impact factor: 3.969

7.  Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.

Authors:  Parveen Kumar; Urban Gullberg; Inge Olsson; Ram Ajore
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

8.  Novel RNA-binding properties of the MTG chromatin regulatory proteins.

Authors:  Stefano Rossetti; Leontine van Unen; Nicoletta Sacchi; Andre T Hoogeveen
Journal:  BMC Mol Biol       Date:  2008-10-24       Impact factor: 2.946

9.  The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues.

Authors:  Rakesh Singh Dhanda; Sofia Rondin Lindberg; Inge Olsson
Journal:  BMC Mol Biol       Date:  2008-01-19       Impact factor: 2.946

10.  Aberrant CBFA2T3B gene promoter methylation in breast tumors.

Authors:  Anthony J Bais; Alison E Gardner; Olivia L D McKenzie; David F Callen; Grant R Sutherland; Gabriel Kremmidiotis
Journal:  Mol Cancer       Date:  2004-08-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.